Literature DB >> 14972324

Mechanisms of genetic susceptibility to type I diabetes: beyond HLA.

Suzana Anjos1, Constantin Polychronakos.   

Abstract

An individual's predisposition to Type I diabetes (T1D) is largely determined by complex interactions between several genetic loci and other, nonheritable factors. In T1D, the HLA locus has been known for decades to contribute 50% of the inherited risk. Outside the HLA are many proposed candidate loci with smaller effects, but only two confirmed candidate genes, the INS-VNTR and the CTLA-4 genes, which together do not contribute more than 15% of the risk. Because of the high frequency of the disease-associated DNA variants of these genes, understanding the biological mechanisms of such DNA variation in the context of T1D can have tremendous impact on the development of preventive therapeutics. However, establishing a causal relationship between common DNA variations and disease-predisposing functional effects is not trivial and remains difficult, as the effects are expected to be subtle. The variable-number tandem-repeat (VNTR) region upstream of the insulin gene is known to mediate expression in the thymus and pancreas, whereas various polymorphisms in the 5' and 3' regulatory regions of CTLA-4 are thought to alter gene expression and a coding A49G polymorphism exerts effects on post-translational processing. This review details the latest efforts in elucidating the functional mechanisms that explain the genetic association of the INS-VNTR and CTLA-4 genes with T1D.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14972324     DOI: 10.1016/j.ymgme.2003.11.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  21 in total

Review 1.  Detecting shared pathogenesis from the shared genetics of immune-related diseases.

Authors:  Alexandra Zhernakova; Cleo C van Diemen; Cisca Wijmenga
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

2.  Prevalence of Autoantibodies and HLA DR, DQ in Type 1 Diabetes Mellitus.

Authors:  Shailja Singh; Gyanendra Singh; Neeraj Kumar Agrawal; Rana Gopal Singh; Shashi Bhushan Kumar
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  Huntingtin-interacting protein 14 is a type 1 diabetes candidate protein regulating insulin secretion and beta-cell apoptosis.

Authors:  Lukas Adrian Berchtold; Zenia Marian Størling; Fernanda Ortis; Kasper Lage; Claus Bang-Berthelsen; Regine Bergholdt; Jacob Hald; Caroline Anna Brorsson; Decio Laks Eizirik; Flemming Pociot; Søren Brunak; Joachim Størling
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-24       Impact factor: 11.205

4.  The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection.

Authors:  Elizabeth P Blankenhorn; Lucy Rodemich; Cristina Martin-Fernandez; Jean Leif; Dale L Greiner; John P Mordes
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

5.  Extreme genetic risk for type 1A diabetes.

Authors:  Theresa A Aly; Akane Ide; Mohamed M Jahromi; Jennifer M Barker; Maria S Fernando; Sunanda R Babu; Liping Yu; Dongmei Miao; Henry A Erlich; Pamela R Fain; Katherine J Barriga; Jill M Norris; Marian J Rewers; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

6.  HLA Antigen Profile Differences in Patients with SCC (Squamous Cell Carcinoma) In-Situ /Actinic Keratosis and Invasive SCC: Is There a Genetic Succeptibility for Invasive SCC Development?

Authors:  Mustafa Atasoy; Rana Anadolu-Braise; Ibrahim Pirim; Hasan Dogan; Mevlüt Ikbal
Journal:  Eurasian J Med       Date:  2009-12

7.  HLA-DQB1* alleles and genetic susceptibility to type 1 diabetes mellitus.

Authors:  Youssef M Mosaad; Fatma A Auf; Shereen S Metwally; Ashraf A Elsharkawy; Amany K El-Hawary; Rasha H Hassan; Ziyad E Tawhid; Farha A El-Chennawi
Journal:  World J Diabetes       Date:  2012-08-15

8.  Yeast one-hybrid screen of a thymus epithelial library identifies ZBTB7A as a regulator of thymic insulin expression.

Authors:  Julien R St-Jean; Houria Ounissi-Benkalha; Constantin Polychronakos
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

9.  Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young.

Authors:  M M Lamb; X Yin; G O Zerbe; G J Klingensmith; D Dabelea; T E Fingerlin; M Rewers; J M Norris
Journal:  Diabetologia       Date:  2009-06-23       Impact factor: 10.122

Review 10.  Type 1 diabetes: primary antigen/peptide/register/trimolecular complex.

Authors:  Tomasz Sosinowski; George S Eisenbarth
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.